Kelyniam Makes History With Revolutionary 24-Hour Turnaround Capabilities

CANTON, Conn., Dec. 13, 2011 /PRNewswire/ -- Kelyniam Global, Inc. (Pinksheets: KLYG), an emerging medical device manufacturing company, announced today it has successfully demonstrated the ability to provide a PEEK-OPTIMA® Custom Skull Implant in as little as 24 hours.

On Saturday, November 26th, at 5:30pm, Kelyniam received the patient's uploaded CT-Data. By 3:30 pm Sunday, the following day, a completed, precision designed, PEEK-OPTIMA® Custom Skull Implant was delivered to the hospital, meeting the needed requirements and a successful procedure soon followed. Until now, 24-hour turn-around service has not been an option offered to surgeons by any other company in the custom cranial implant market.

Kelyniam's President and CEO, Tennyson S. Anthony stated: "We were challenged with an 'emergency case' and we proved that Kelyniam could provide the surgeon with the required implant within a 24 hour time frame. We want everyone to understand that they can 're-think' the way they have ordered custom cranial implants in the past, no longer needing to schedule surgeries with a 4-6 week lead time due to slow turnaround times."  Mr. Anthony added: "Surgeons across the U.S. are reporting unmatched precision and results using Kelyniam's Custom Skull Implants. Whether it's a need for precision fit, proven PEEK material, or fast turnaround, Kelyniam is prepared to deliver to the world. We are proud of our accomplishments and promise to never compromise with product or patient care. We believe our fast turnaround time provides surgeons additional treatment options, and improves the patient's quality of life by getting them on the path to recovery in less time."

Kelyniam Custom Skull Implants (CSI) are designed and manufactured for each individual patient to correct or replace bony voids in the cranial skeleton caused by trauma, disease or congenital birth defects. Streamlined CAD/CAM design and manufacturing techniques enable Kelyniam to deliver precision fit, patient specific implants to surgeons in as little as 24 hours from the receipt of an order if needed.

About Kelyniam Global, Incorporated

Kelyniam Global (Pinksheets: KLYG), Inc. specializes in the use of CAD/CAM technology to provide patient specific custom implants to assist medical professionals by allowing them to operate more effectively, improve patient care, and reduce health care costs by providing the highest quality products available with today's technology. The company is continually researching and developing new products and processes to help patients live more active and productive lives.

Please visit our website at www.kelyniam.com for more information.

Forward-Looking Statements

Except for historical information contained in this release, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this release, words such as "anticipate," "believes," "estimate," "expect," "should," "intend," "projects," "objective" and "appears" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and pricing; capacity and supply constraints or difficulties; product development, commercialization or technological difficulties; the regulatory and trade environment; the impact of reimbursement rates and coverage; and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to revise any forward-looking statements as a result of future events or developments.

For Question regarding this Press Release, please contact:
Kelyniam
[email protected]
www.kelyniam.com
800-280-8192

SOURCE Kelyniam Global, Inc.